IgA Vasculitis Following COVID-19 Vaccination

Area of Science:

• Immunology
• Nephrology
• Vaccinology

Background:

• Emerging SARS-CoV-2 variants necessitate widespread COVID-19 vaccination.
• Rare adverse events following COVID-19 vaccination are increasingly reported.
• IgA vasculitis is a common childhood vasculitis, occasionally affecting adults.

Observation:

• A 72-year-old patient presented with palpable purpura two weeks post-Pfizer-BioNTech vaccination.
• Clinical presentation included elevated creatinine, significant albuminuria, and macroscopic hematuria.
• Histopathology confirmed necrotizing vasculitis consistent with IgA vasculitis.

Findings:

• The patient was diagnosed with IgA vasculitis.
• The temporal association between vaccination and symptom onset suggests a potential causal link.
• This case adds to the literature on rare post-vaccination adverse events.

Implications:

• This case underscores the importance of monitoring for rare side effects of COVID-19 vaccines.
• Further research is needed to understand the mechanisms linking COVID-19 vaccines to IgA vasculitis.
• Healthcare providers should consider IgA vasculitis in patients presenting with relevant symptoms after vaccination.